Introducing the Newest Line of Cold Lasers from Erchonia® One revolutionary new handheld laser device with three FDA 510(k)market clearances. This dual-diode laser features an easy to use graphical user interface (GUI), with a sleek new cord-free design. With user…
“This new technology is a breakthrough for chronic heel pain sufferers, because it offers pain-free treatment with no known side effects or contraindications. “ Erchonia today announces the U.S. Food and Drug Administration (FDA) has granted the company 510 (k)…
Erchonia today announces that the preliminary results of an ongoing clinical trial testing its Lunula laser for the noninvasive treatment of nail fungus have been published in the latest issue of the medical journal Podiatry Review. “I am pleased to…
Tuesday, August 6th 2013 In the latest volume of the medical journal, Lasers in Surgery and Medicine, three Harvard scientists concluded that Erchonia’s research for its Zerona low-level laser device has, “set the precedent on how aesthetic devices should be…
Contact: Katie Cycan Crier Communications 310-274-1072 x 207 [email protected] New Clinical Trial Proves Erchonia’s Verjú Laser System Safely and Effectively Improves the Appearance of Cellulite McKinney, TX – June 24, 2013 – Erchonia today announces its new Verjú low level laser system has been proven to…
FDA Grants Market Clearance for Erchonia’s Zerona Laser Proven safe and effective for circumference reduction of the waist, hips and thighs Erchonia Corporation, the world’s leading manufacturer in low-level laser technology, has been granted market clearance by the U.S. Food…
Top Rated Daytime Talk Show Features a Dramatic Zerona Makeover Erchonia Corporation, the leading low level laser technology manufacturer in the United States, today announces the company’s Zerona laser will be featured on an episode of CBS’s hit show “The…
